ATE42466T1 - Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis. - Google Patents
Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis.Info
- Publication number
- ATE42466T1 ATE42466T1 AT85400073T AT85400073T ATE42466T1 AT E42466 T1 ATE42466 T1 AT E42466T1 AT 85400073 T AT85400073 T AT 85400073T AT 85400073 T AT85400073 T AT 85400073T AT E42466 T1 ATE42466 T1 AT E42466T1
- Authority
- AT
- Austria
- Prior art keywords
- manufacture
- preventing
- treatment
- pseudomembrancolitis
- medication
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/94—Saccharomyces
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/571,523 US4595590A (en) | 1984-01-17 | 1984-01-17 | Method for preventing or treating pseudo-membranous colitis |
EP85400073A EP0149579B1 (de) | 1984-01-17 | 1985-01-16 | Verwendung von Saccharomyces Hefen zur Herstellung eines Medikaments zur Verhütung oder Behandlung von Pseudomembrankolitis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE42466T1 true ATE42466T1 (de) | 1989-05-15 |
Family
ID=24284058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85400073T ATE42466T1 (de) | 1984-01-17 | 1985-01-16 | Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis. |
Country Status (4)
Country | Link |
---|---|
US (1) | US4595590A (de) |
EP (1) | EP0149579B1 (de) |
AT (1) | ATE42466T1 (de) |
DE (1) | DE3569673D1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0195870B1 (de) * | 1985-03-22 | 1990-01-31 | Laboratoires BIOCODEX | Verwendung von Saccharomyces-Hefen für die Herstellung eines Arzneimittels gegen Amöbiasis |
US4960591A (en) * | 1989-04-17 | 1990-10-02 | Gribou Henry G | Methods and compositions for relief of stomach distress |
FR2707458B1 (fr) * | 1993-07-12 | 1995-10-06 | Sagal | Ingrédients alimentaires obtenus par fermentation avec S. Boulardii et aliments les contenant. |
FR2711528B1 (fr) * | 1993-10-25 | 1996-02-09 | Biocodex Lab | Utilisation de levures Saccharomyces pour la fabrication d'un médicament contre la cryptosporidiose. |
DE4336888A1 (de) * | 1993-10-28 | 1995-05-04 | Thiemann Arzneimittel Gmbh | Produkt, erhältlich aus Hefezellen von Saccharomyces boulardii und dessen Verwendung |
TW200520767A (en) * | 2003-10-13 | 2005-07-01 | Nestec Sa | Moderating the effect of endotoxins |
WO2005039606A2 (en) * | 2003-10-13 | 2005-05-06 | Nestec S.A. | Moderating the effect of endotoxins |
US20080226614A1 (en) * | 2004-08-23 | 2008-09-18 | Krishna Murthy Ella | Eukaryotic Based Synergistic Formulation for Gastro-Intestinal Disorders |
US7799328B2 (en) * | 2004-12-23 | 2010-09-21 | Biocodex | Method for treating weight loss in patients suffering from inflammatory bowel diseases |
RU2427389C2 (ru) | 2009-10-09 | 2011-08-27 | Александр Владимирович Диковский | Фармацевтическая композиция для профилактики и лечения инфекционных и неинфекционных диарей |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL146908B (nl) * | 1948-06-14 | Tecalemit Engineering | Pomp. | |
GB930107A (en) * | 1960-01-11 | 1963-07-03 | Giuseppe Carlo Sigurta | Therapeutic oral preparation of micro-organisms |
FR1538957A (fr) * | 1964-02-17 | 1968-09-13 | Robert & Carriere Lab | Perfectionnement à la culture des levures |
BE652331A (de) * | 1964-08-26 | 1965-02-26 | ||
FR2096887A1 (en) * | 1970-07-10 | 1972-03-03 | Griffon Henri | Compsn contg dried yeast with high living cell count - - for dietetic use and treating intestinal disorders |
FR2228470A1 (en) * | 1973-05-09 | 1974-12-06 | Degemont Marguerite | Therapeutic compsn. contg. vitamin A, sulphur and live yeast - for treatment of disorders of the ear, nose and throat |
US4265913A (en) * | 1974-03-05 | 1981-05-05 | Eichelburg Robert J | Oral ingesta for animals |
US4138479A (en) * | 1975-11-07 | 1979-02-06 | Bayer Aktiengesellschaft | Process for the preparation of immunopotentiating agents from components of yeast cell wall material |
-
1984
- 1984-01-17 US US06/571,523 patent/US4595590A/en not_active Expired - Lifetime
-
1985
- 1985-01-16 DE DE8585400073T patent/DE3569673D1/de not_active Expired
- 1985-01-16 AT AT85400073T patent/ATE42466T1/de not_active IP Right Cessation
- 1985-01-16 EP EP85400073A patent/EP0149579B1/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0149579B1 (de) | 1989-04-26 |
DE3569673D1 (en) | 1989-06-01 |
EP0149579A3 (en) | 1986-03-05 |
EP0149579A2 (de) | 1985-07-24 |
US4595590A (en) | 1986-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10199020I2 (de) | Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit. | |
DE122005000002I1 (de) | Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz. | |
ATE324884T1 (de) | Verwendung von gamma-linolensäure oder dihomogammalinolensäure zur herstellung eines medikaments zur behandlung von huntington's chorea | |
ATE93143T1 (de) | Verwendung eines lysozymdimeren und/oder ribonucleasedimeren zur herstellung eines antiviralen oder antibakteriellen arzneimittels. | |
DE3482754D1 (de) | Medikament und medikamentoese zusammensetzung zur behandlung und/oder verhinderung von hautkrankheiten, verursacht durch eine entzuendung. | |
DE3752112T2 (de) | Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen | |
DE69328438D1 (de) | Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung | |
DE3582439D1 (de) | Mittel zur behandlung von herzerkrankungen. | |
DE69431476T2 (de) | Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung | |
IE40860L (en) | N- heterocyclylalkylbenzamides | |
ATE42466T1 (de) | Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis. | |
ATE78171T1 (de) | Gangliosidgemisch zur verwendung als therapeutisches hilfsmittel zur schmerzunterdrueckung bei peripheren neuropathien. | |
FI850649L (fi) | Kompress samt foerfarande foer dess framstaellning. | |
AU7426487A (en) | Method of treating depression using d-fenfluramine | |
DE3268159D1 (en) | Medicaments based on algae, and formulations thereof | |
ES8609461A1 (es) | Un procedimiento para preparar una composicion para el tra- tamiento de fuego bacteriano en plantas | |
DE3575671D1 (de) | Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis. | |
GEP20012511B (en) | Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis | |
DE69623316D1 (de) | Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen | |
DE3486005T2 (de) | Anwendung von carbamate oder thiocarbamat-derivaten zur behandlung von fungus-infektionen. | |
ATE107166T1 (de) | Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration. | |
ATE62789T1 (de) | Mittel zur bekaempfung von phytopathogenen mikroben. | |
AU4042795A (en) | Treatment of non-small cell lung carcinoma | |
ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen | |
EP0278715A3 (de) | Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |